If It''s Planned, Will They Build It? How Many Pharma-Biotech Capital Projects Actually Make Construction? -- An Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwired) -- 01/19/15 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- When considering the ''s reported capital project spending for any given year, it is important to analyze the projects after they are first reported. Utilizing analysis tools, such as Gap Measurement and Project Fallout, help to illuminate an accurate view of project-spending patterns. From 2012-14, 71% of reported pharma-biotech projects in a given year made it to construction.
Within this article: Outlook for cash-intensive projects in the Pharmaceutical-Biotech Industry.
For details, , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info''s quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what''s happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
William Ploch
713-783-5147
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 19.01.2015 - 05:15 Uhr
Sprache: Deutsch
News-ID 1330913
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SUGAR LAND, TX
Phone:
Kategorie:
Health & Nutrition
Anmerkungen:
Diese Pressemitteilung wurde bisher 279 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"If It''s Planned, Will They Build It? How Many Pharma-Biotech Capital Projects Actually Make Construction? -- An Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
